Taiwan · Delayed Price · Currency is TWD WeLeader Biomedical Statistics
Total Valuation
TPEX:7713 has a market cap or net worth of TWD 3.34 billion. The enterprise value is 4.20 billion.
| Market Cap | 3.34B |
| Enterprise Value | 4.20B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | Mar 27, 2026 |
Share Statistics
TPEX:7713 has 45.48 million shares outstanding. The number of shares has increased by 15.19% in one year.
| Current Share Class | 45.48M |
| Shares Outstanding | 45.48M |
| Shares Change (YoY) | +15.19% |
| Shares Change (QoQ) | -1.86% |
| Owned by Insiders (%) | 21.29% |
| Owned by Institutions (%) | n/a |
| Float | 8.15M |
Valuation Ratios
The trailing PE ratio is 14.55.
| PE Ratio | 14.55 |
| Forward PE | n/a |
| PS Ratio | 2.76 |
| PB Ratio | 2.78 |
| P/TBV Ratio | 2.80 |
| P/FCF Ratio | 18.14 |
| P/OCF Ratio | 10.16 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.54, with an EV/FCF ratio of 22.79.
| EV / Earnings | 16.85 |
| EV / Sales | 3.47 |
| EV / EBITDA | 9.54 |
| EV / EBIT | 13.55 |
| EV / FCF | 22.79 |
Financial Position
The company has a current ratio of 1.55, with a Debt / Equity ratio of 0.82.
| Current Ratio | 1.55 |
| Quick Ratio | 1.08 |
| Debt / Equity | 0.82 |
| Debt / EBITDA | 2.22 |
| Debt / FCF | 5.31 |
| Interest Coverage | 21.97 |
Financial Efficiency
Return on equity (ROE) is 21.80% and return on invested capital (ROIC) is 13.55%.
| Return on Equity (ROE) | 21.80% |
| Return on Assets (ROA) | 8.34% |
| Return on Invested Capital (ROIC) | 13.55% |
| Return on Capital Employed (ROCE) | 14.96% |
| Weighted Average Cost of Capital (WACC) | 3.79% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.52 |
| Inventory Turnover | 6.15 |
Taxes
In the past 12 months, TPEX:7713 has paid 60.92 million in taxes.
| Income Tax | 60.92M |
| Effective Tax Rate | 19.64% |
Stock Price Statistics
The stock price has increased by +5.20% in the last 52 weeks. The beta is 0.06, so TPEX:7713's price volatility has been lower than the market average.
| Beta (5Y) | 0.06 |
| 52-Week Price Change | +5.20% |
| 50-Day Moving Average | 70.71 |
| 200-Day Moving Average | 71.19 |
| Relative Strength Index (RSI) | 72.82 |
| Average Volume (20 Days) | 13,971 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:7713 had revenue of TWD 1.21 billion and earned 249.24 million in profits. Earnings per share was 5.05.
| Revenue | 1.21B |
| Gross Profit | 424.28M |
| Operating Income | 309.92M |
| Pretax Income | 310.16M |
| Net Income | 249.24M |
| EBITDA | 344.04M |
| EBIT | 309.92M |
| Earnings Per Share (EPS) | 5.05 |
Balance Sheet
The company has 122.73 million in cash and 978.95 million in debt, with a net cash position of -856.22 million or -18.83 per share.
| Cash & Cash Equivalents | 122.73M |
| Total Debt | 978.95M |
| Net Cash | -856.22M |
| Net Cash Per Share | -18.83 |
| Equity (Book Value) | 1.20B |
| Book Value Per Share | 26.40 |
| Working Capital | 248.12M |
Cash Flow
In the last 12 months, operating cash flow was 329.16 million and capital expenditures -144.91 million, giving a free cash flow of 184.25 million.
| Operating Cash Flow | 329.16M |
| Capital Expenditures | -144.91M |
| Depreciation & Amortization | 34.12M |
| Net Borrowing | 3.68M |
| Free Cash Flow | 184.25M |
| FCF Per Share | 4.05 |
Margins
Gross margin is 35.09%, with operating and profit margins of 25.63% and 20.61%.
| Gross Margin | 35.09% |
| Operating Margin | 25.63% |
| Pretax Margin | 25.65% |
| Profit Margin | 20.61% |
| EBITDA Margin | 28.45% |
| EBIT Margin | 25.63% |
| FCF Margin | 15.24% |
Dividends & Yields
This stock pays an annual dividend of 4.10, which amounts to a dividend yield of 5.77%.
| Dividend Per Share | 4.10 |
| Dividend Yield | 5.77% |
| Dividend Growth (YoY) | 21.73% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 74.81% |
| Buyback Yield | -15.19% |
| Shareholder Yield | -9.41% |
| Earnings Yield | 7.46% |
| FCF Yield | 5.51% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TPEX:7713 has an Altman Z-Score of 2.66 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.66 |
| Piotroski F-Score | 6 |